Navigation Links
Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference
Date:9/20/2010

Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference -- N. BILLERICA, Mass., Sept. 20 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference

 

N. BILLERICA, Mass., Sept. 20 /PRNewswire/ -- Seahorse Bioscience, Inc., the leading manufacturer of instruments and consumables for measuring cellular metabolism announced today that Chief Executive Officer, Jay Teich, will present at the 2010 UBS Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. EDT at the Grand Hyatt Hotel in New York City.  Mr. Teich will highlight the company's strategy for maintaining rapid growth of 85% CAGR in a new $1BB Life Science Cellular Bioenergetics market.  "We believe that we are at the right place at the right time to ride a wave of interest in cell bioenergetics as it applies to Cancer, Obesity, Diabetes, Ageing and Cardiovascular function," proclaimed Mr. Teich.

A live webcast of the conference can be viewed at http://cc.talkpoint.com/ubsx001/092110a_lv/

About Seahorse Bioscience Seahorse XF instruments are the new standard in cellular bioenergetic measurements.  More than 600 scientists in 20 countries are utilizing the award-winning XF Analyzers to advance their research into the role of mitochondrial (dys)function and its implications in diseases.  Founded in 2001, Seahorse is headquartered in Billerica, MA.  For more information, visit http://www.seahorsebio.com.Seahorse Bioscience, Inc.Media Contact: Cynthia EganPhone: 978.671.1610
'/>"/>

SOURCE Seahorse Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. TheScientist Awards Seahorse XF96 Analyzer a Top Ten Innovation for 2009
2. Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference
3. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
4. Seahorse Bioscience, Inc. Acquires BioProcessors Corp.
5. Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City
6. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
7. EUCODIS Bioscience Appoints Two Industry Executives to Realigned Advisory Board
8. Cardio3 BioSciences Publishes the Science Basis for C-Cure(R) in JACC
9. Signum Biosciences Names Braham Shroot as Chief Executive Officer
10. YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study
11. CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... RADNOR, Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), ... to laboratory and production customers, today reported its financial results ... 2016. Highlights: 4Q16 record ... up 1.0% on an organic basis. ... on an organic basis, while the Americas net sales increased ...
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, ... begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. ... healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed on ...
Breaking Biology Technology:
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):